The pharmaceutical company expects the expansion will create thousands of jobs.
Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
Following the results of a study by USC Annenberg Inclusion Initiative demonstrating the lack of adequate representation of ...
Eli Lilly stock surges past $840, outperforming the S&P 500. Click here to learn why LLY stock is still undervalued and why ...
Eli LIlly & Co. said Tuesday it is launching 7.5 and 10 milligram versions of its Zepbound single-dose vials at a price of $499-a-month for self-pay patients, down from $699 previously.
Eli Lilly kicks off 2025 with key licensing deals and M&A, boosting its position across therapeutic areas amid rising drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback